Clinical Trial: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years

U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07156201) titled 'A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years' on Aug. 25.

Brief Summary: This first in human trial will evaluate the safety, tolerability, and pharmacokinetics of single ascending doses, multiple ascending doses, and fed and fasted doses of ABS-1230 given orally compared with placebo in adult healthy participants.

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: KCNT1-Related Epilepsy

Intervention: DRUG: ABS-1230

ABS-1230

DRUG: Placebo

Placebo

Recruitment Status: RECRUITING

Sponsor: Actio ...